Skip to content

Effect of liposomal bupivacaine for postoperative analgesia after total knee arthroplasty: a randomized, controlled, double-blind trial

Effect of liposomal bupivacaine for postoperative analgesia after total knee arthroplasty: a randomized, controlled, double-blind trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082998
Enrollment
Unknown
Registered
2024-04-12
Start date
2024-04-22
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee joint disease

Interventions

Liposomal bupivacaine group:Mixture of liposomal bupivacaine and ropivacaine local infiltration analgesia
Ropivacaine group: Ropivacaine local infiltration analgesia

Sponsors

The First People's Hospital of Changzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age: 18-75 years old Gender: Both BMI 18-35kg/m2 American Society of Anesthesiologists Class I, II, and III Elective unilateral total knee arthroplasty Written informed consent was obtained

Exclusion criteria

Exclusion criteria: Decline to attend Be pregnant Situations in which the patient is unable to complete the questionnaire online via email or telephone, including cognitive dysfunction, mental disorders Coagulation disorder Local anesthetics should not be used for allergies or any other reason Analgesic drug abuse Insulin-dependent or uncontrolled diabetes is defined as blood glucose >200mg/dl or hemoglobin A1C > 8.0% on the day of surgery Peripheral nerve block or systemic infection Immune impairment (e.g., HIV, long-term glucocorticoid use) Severe pre-existing neuropathy Revision TKA or bilateral TKA Severe hepatic and renal dysfunction (GFR <50 ml/min, Child-Pugh grade C) Patients with active or latent peptic ulcer, diverticulitis, fresh intestinal anastomosis, and nonspecific ulcerative colitis

Design outcomes

Primary

MeasureTime frame
Numerica Rating Scale 72h after surgery;

Secondary

MeasureTime frame
Get out of bed for the first time;Length Of Stay, LOS;Postoperative complications;

Countries

China

Contacts

Public ContactChen Chen

The First People's Hospital of Changzhou

chenchennjmu@outlook.com+86 135 0611 6811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 6, 2026